Fast track — ArticlesSurvival after surgery for oesophageal cancer: a population-based study
Introduction
Oesophageal cancer is the eighth most common cancer worldwide.1 During the past three decades, the incidence of oesophageal adenocarcinoma has increased rapidly in most developed countries, whereas that of squamous-cell carcinoma has been more stable.2, 3, 4 Patients with either histological type have a poor outlook (ie, overall 5-year survival of 10% or less in Europe).5 However, some studies have shown improved survival during recent years, including one from Sweden.6 Tumour stage is the strongest known prognostic factor of survival.7 Furthermore, because most randomised trials8, 9, 10, 11 have not shown a long-term survival advantage for adjuvant chemoradiotherapy, surgical resection alone remains the only potentially curative treatment for patients with oesophageal cancer.12, 13 Studies done at one institution suggest that surgery offers a 25–35% chance of cure and that survival has improved rates in recent years;13, 14 however potential selection bias hinders interpretation of these reports.
Few population-based studies that assess the effect of tumour stage on survival have been done. Therefore, survival after surgery for oesophageal cancer surgery in a population-based setting remains unknown, and any apparent improvement with time is uncertain. We aimed to do a population-based study to assess short-term and long-term outlook after surgery (ie, resection) for oesophageal cancer in Sweden, with complete follow-up and access to all relevant potential confounding factors. We postulated that survival after surgery for oesophageal cancer has improved since 1987 because of improved surgical quality.
Section snippets
Study design
Patients with oesophageal cancer were identified through the Swedish cancer register by employees at the registry. Surgical procedures (including the type of surgery, date of surgery, and hospital where the operation was done) and comorbidities were assessed by employees at the Swedish Board of Health and Welfare using the Swedish inpatient register. Tumour stage, location, and histological type were verified by IR, who reviewed histopathological records of the resected tumours. To obtain
Results
From the cancer register, we identified 4904 patients who were diagnosed with oesophageal cancer between 1987 and 2000, 1199 (24%) of whom had surgical resection. After exclusion of 391 (33%) patients who had received preoperative treatment for cancer and 44 (4%) patients with missing data, 764 (64%) patients who had had oesophageal resection alone remained for analysis. Histopathological records were obtained for 750 (98%) patients; tumour stage for 14 patients with missing histopathological
Discussion
We have shown that short-term and long-term survival after surgery for oesophageal cancer in Sweden has improved since 1987.
The complete nationwide and population-based design, which included all patients with oesophageal cancer treated with surgery, was an advantage of our study. Such a design importantly counteracts selection bias and ensures generalisability of the findings. The complete follow-up, length of observation, uniform staging of tumours according to modern standards, access to
References (23)
Global cancer statistics in the year 2000
Lancet Oncol
(2001)- et al.
Introduction: the EUROCARE II Study
Eur J Cancer
(1998) - et al.
Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers
Clin Gastroenterol Hepatol
(2005) - et al.
Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis
Surgery
(2005) - et al.
The role of surgery in the management of oesophageal cancer
Lancet Oncol
(2003) - et al.
Demographic variations in the rising incidence of esophageal adenocarcinoma in white males
Cancer
(2001) - et al.
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Cancer
(1998) - et al.
Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden
Int J Cancer
(1993) - et al.
Improved survival in both histologic types of oesophageal cancer in Sweden
Int J Cancer
(2002) - et al.
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus
N Engl J Med
(1997)
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
N Engl J Med
Cited by (179)
Hospital costs and health-related quality of life from complications after esophagectomy
2021, European Journal of Surgical OncologyThe association between the inflammatory response to surgery and postoperative complications in older patients with cancer; a prospective prognostic factor study
2020, Journal of Geriatric OncologyCitation Excerpt :The CCI was designed to quantify the risk of mortality over a one-year period after inpatient admission to the hospital by a weighted score computed by presence or absence of 19 comorbidities [40]. Given previous reports that found comorbidity as a predictor of outcomes in different surgical oncological populations, it is not unexpected that comorbidities were found to be associated with postoperative complications in older patients [8,41,42]. Our study underscores that older men are at increased risk compared to women for the development of complications [43,44].
Annual hospital volume of surgery for gastrointestinal cancer in relation to prognosis
2019, European Journal of Surgical OncologySurgical approach for esophageal cancer
2023, Chinese Journal of Gastrointestinal Surgery / Zhonghua Wei Chang Wai Ke Za ZhiExtent of Lymphadenectomy and Long-term Survival in Esophageal Cancer
2023, Annals of Surgery